학술논문

The SWI/SNF chromatin remodeling subunit DPF2 facilitates NRF2-dependent anti-inflammatory and anti-oxidant gene expression
Document Type
article
Source
Journal of Clinical Investigation. 133(13)
Subject
Hematology
Genetics
Cancer
Biotechnology
Regenerative Medicine
Stem Cell Research
Stem Cell Research - Nonembryonic - Non-Human
Vaccine Related
Aetiology
Underpinning research
1.1 Normal biological development and functioning
2.1 Biological and endogenous factors
Inflammatory and immune system
Mice
Animals
Chromatin
Antioxidants
NF-E2-Related Factor 2
Neoplasms
Chromatin Assembly and Disassembly
Inflammation
Gene Expression
DNA-Binding Proteins
Transcription Factors
Epigenetics
Hematopoietic stem cells
Macrophages
Medical and Health Sciences
Immunology
Language
Abstract
During emergency hematopoiesis, hematopoietic stem cells (HSCs) rapidly proliferate to produce myeloid and lymphoid effector cells, a response that is critical against infection or tissue injury. If unresolved, this process leads to sustained inflammation, which can cause life-threatening diseases and cancer. Here, we identify a role of double PHD fingers 2 (DPF2) in modulating inflammation. DPF2 is a defining subunit of the hematopoiesis-specific BAF (SWI/SNF) chromatin-remodeling complex, and it is mutated in multiple cancers and neurological disorders. We uncovered that hematopoiesis-specific Dpf2-KO mice developed leukopenia, severe anemia, and lethal systemic inflammation characterized by histiocytic and fibrotic tissue infiltration resembling a clinical hyperinflammatory state. Dpf2 loss impaired the polarization of macrophages responsible for tissue repair, induced the unrestrained activation of Th cells, and generated an emergency-like state of HSC hyperproliferation and myeloid cell-biased differentiation. Mechanistically, Dpf2 deficiency resulted in the loss of the BAF catalytic subunit BRG1 from nuclear factor erythroid 2-like 2-controlled (NRF2-controlled) enhancers, impairing the antioxidant and antiinflammatory transcriptional response needed to modulate inflammation. Finally, pharmacological reactivation of NRF2 suppressed the inflammation-mediated phenotypes and lethality of Dpf2Δ/Δ mice. Our work establishes an essential role of the DPF2-BAF complex in licensing NRF2-dependent gene expression in HSCs and immune effector cells to prevent chronic inflammation.